» Articles » PMID: 25867271

MiR-367 Promotes Epithelial-to-mesenchymal Transition and Invasion of Pancreatic Ductal Adenocarcinoma Cells by Targeting the Smad7-TGF-β Signalling Pathway

Overview
Journal Br J Cancer
Specialty Oncology
Date 2015 Apr 14
PMID 25867271
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aberrant Smad7 expression contributes to the invasion and metastasis of pancreatic cancer cells. However, the potential mechanism underlying aberrant Smad7 expression in human pancreatic ductal adenocarcinoma (PDAC) remains largely unknown.

Methods: Bioinformatic prediction programmes and luciferase reporter assay were used to identify microRNAs regulating Smad7. The association between miR-367 expression and the overall survival of PDAC patients was evaluated by Kaplan-Meier analysis. The effects of miR-367 and Smad7 on the invasion and metastasis of pancreatic cancer cells were investigated both in vitro and in vivo.

Results: We found that miR-367 downregulated Smad7 expression by directly targeting its 3'-UTR in human pancreatic cancer cells. High level of miR-367 expression correlated with poor prognosis of PDAC patients. Functional studies showed that miR-367 promoted pancreatic cancer invasion in vitro and metastasis in vivo through downregulating Smad7. In addition, we showed that miR-367 promoted epithelial-to-mesenchymal transition by increasing transforming growth factor-β (TGF-β)-induced transcriptional activity.

Conclusions: The present study identified and characterised a signalling pathway, the miR-367/Smad7-TGF-β pathway, which is involved in the invasion and metastasis of pancreatic cancer cells. Our results suggest that miR-367 may be a promising therapeutic target for the treatment of human pancreatic cancer.

Citing Articles

More than the SRY: The Non-Coding Landscape of the Y Chromosome and Its Importance in Human Disease.

Westemeier-Rice E, Winters M, Rawson T, Martinez I Noncoding RNA. 2024; 10(2).

PMID: 38668379 PMC: 11054740. DOI: 10.3390/ncrna10020021.


MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.

Wei X, Jiang Y, Yang G, Chang T, Sun G, Chen S J Cancer Res Clin Oncol. 2023; 149(20):17807-17821.

PMID: 37935937 PMC: 10725407. DOI: 10.1007/s00432-023-05484-6.


Pluripotency-Associated microRNAs in Early Vertebrate Embryos and Stem Cells.

Maraghechi P, Aponte M, Ecker A, Lazar B, Toth R, Szabadi N Genes (Basel). 2023; 14(7).

PMID: 37510338 PMC: 10379376. DOI: 10.3390/genes14071434.


An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?.

Armando F, Mazzola F, Ferrari L, Corradi A Vet Sci. 2023; 10(1).

PMID: 36669020 PMC: 9865109. DOI: 10.3390/vetsci10010019.


miRNA in Molecular Diagnostics.

Matulic M, Grskovic P, Petrovic A, Begic V, Harabajsa S, Korac P Bioengineering (Basel). 2022; 9(9).

PMID: 36135005 PMC: 9495386. DOI: 10.3390/bioengineering9090459.


References
1.
Hata A, Lagna G, Massague J, Hemmati-Brivanlou A . Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 1998; 12(2):186-97. PMC: 316444. DOI: 10.1101/gad.12.2.186. View

2.
Javelaud D, Mohammad K, McKenna C, Fournier P, Luciani F, Niewolna M . Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res. 2007; 67(5):2317-24. DOI: 10.1158/0008-5472.CAN-06-3950. View

3.
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M . N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res. 2004; 10(12 Pt 1):4125-33. DOI: 10.1158/1078-0432.CCR-0578-03. View

4.
Kim Y, Lee H, Lee H, Hur K, Kim W, Bang Y . Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol. 2004; 15(4):574-80. DOI: 10.1093/annonc/mdh131. View

5.
Shi W, Sun C, He B, Xiong W, Shi X, Yao D . GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol. 2004; 164(2):291-300. PMC: 2172339. DOI: 10.1083/jcb.200307151. View